A Prospective Database of Infants With Cholestasis

NCT00061828 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-10-15

No results posted yet for this study

Summary

Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.

Conditions

  • Biliary Atresia

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • Arbor Research Collaborative for Health

    lead OTHER

Principal Investigators

  • Saul Karpen, MD, PhD · VCU School of Medicine

  • Ed Doo, MD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

  • John Magee, MD · University of Michigan Medical Center, Ann Arbor

  • Lisa Henn, PhD · Arbor Research Collaborative for Health

  • Katrina Loh, MD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-21
Primary Completion
2029-05-31
Completion
2029-05-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00061828 on ClinicalTrials.gov